[{"address1": "3222 Phoenixville Pike", "city": "Malvern", "state": "PA", "zip": "19355", "country": "United States", "phone": "610 640 4202", "fax": "610 640 4206", "website": "https://neurostar.com", "industry": "Diagnostics & Research", "industryKey": "diagnostics-research", "industryDisp": "Diagnostics & Research", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.", "fullTimeEmployees": 201, "companyOfficers": [{"maxAge": 1, "name": "Mr. Keith J. Sullivan", "age": 66, "title": "President, CEO & Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 1389285, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Stephen J. Furlong M.S.", "age": 60, "title": "Executive VP, CFO & Treasurer", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 771385, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. W. Andrew Macan J.D.", "age": 51, "title": "Executive VP, GC, Chief Compliance Officer & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 629703, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Rusty  Page", "title": "Senior VP of Operations & Quality", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Metzner-Rosas", "title": "Senior VP & Chief Marketing Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sara  Grubbs", "title": "Senior VP & Chief Revenue Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Cory S. Anderson", "title": "Senior Vice President of R&D and Clinical", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.9, "open": 4.04, "dayLow": 3.97, "dayHigh": 4.57, "regularMarketPreviousClose": 3.9, "regularMarketOpen": 4.04, "regularMarketDayLow": 3.97, "regularMarketDayHigh": 4.57, "beta": 2.169, "forwardPE": -6.893281, "volume": 3029612, "regularMarketVolume": 3029612, "averageVolume": 922828, "averageVolume10days": 2147500, "averageDailyVolume10Day": 2147500, "bid": 3.24, "ask": 5.1, "bidSize": 200, "askSize": 200, "marketCap": 277524896, "fiftyTwoWeekLow": 0.52, "fiftyTwoWeekHigh": 5.07, "priceToSalesTrailing12Months": 3.8168213, "fiftyDayAverage": 2.093, "twoHundredDayAverage": 1.642795, "currency": "USD", "enterpriseValue": 160145120, "profitMargins": -0.50093, "floatShares": 14467566, "sharesOutstanding": 63652500, "sharesShort": 1284532, "sharesShortPriorMonth": 312933, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0231, "heldPercentInsiders": 0.085080005, "heldPercentInstitutions": 0.59919, "shortRatio": 1.04, "shortPercentOfFloat": 0.0239, "impliedSharesOutstanding": 63652500, "bookValue": 0.309, "priceToBook": 14.110033, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -36423000, "trailingEps": -1.22, "forwardEps": -0.62, "enterpriseToRevenue": 2.202, "enterpriseToEbitda": -6.821, "52WeekChange": 0.2871287, "SandP52WeekChange": 0.22903383, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "STIM", "underlyingSymbol": "STIM", "shortName": "Neuronetics, Inc.", "longName": "Neuronetics, Inc.", "firstTradeDateEpochUtc": 1530192600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "4ad9195a-9581-3ad1-ac20-8818643be5c9", "messageBoardId": "finmb_3177427", "gmtOffSetMilliseconds": -18000000, "currentPrice": 4.36, "targetHighPrice": 5.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.33333, "targetMedianPrice": 3.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 20867000, "totalCashPerShare": 0.688, "ebitda": -23478000, "totalDebt": 48697000, "quickRatio": 2.436, "currentRatio": 3.164, "totalRevenue": 72711000, "debtToEquity": 519.102, "revenuePerShare": 2.446, "returnOnAssets": -0.19088, "returnOnEquity": -1.53937, "grossProfits": 56939000, "freeCashflow": -10625875, "operatingCashflow": -20268000, "revenueGrowth": 0.036, "grossMargins": 0.78309, "ebitdaMargins": -0.32289, "operatingMargins": -0.41705, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-15"}]